Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
About
Abnormal Involuntary Movement Scale
Acamprosate, preventing relapse after alcohol detoxification
acetylcholinesterase inhibitors (AChE-Is) Alzheimer's disease Management of behavioural and psychological symptoms of dementia Mild cognitive impairment Other dementias 647, ,649 Use in Parkinson's disease Dementia with Lewy bodies Mechanism of action 630, Older patients and dementia Rare dementias associated with neurological conditions Vascular dementia
Activated partial thromboplastin time, psychotropic agent effects
Acute behavioural disturbance
Acutely disturbed/violent behaviour oral/inhaled treatment practical measures Acutely disturbed or violent behaviour parenteral treatment zuclopenthixol acetate
Acute mania, treatments
adapted Naranjo adverse drug reaction scale
Administration of medicines alternative routes site of intramuscular injections covertly in food and drink, older people 629,
Adolescents bulimia nervosa/binge eating disorder adrenergic a2 agonists, tics and Tourette's syndrome
ADRs - see adverse drug reactions
adverse drug reactions adapted Naranjo adverse drug reaction scale
Age effects changes in pharmacodynamics depression in children and adolescents
Aggressive behaviours paradoxical/disinhibitory drug reactions, benzodiazepines valproate treatment
Agomelatine in overdose smokers
Agonist replacement therapy, limited evidence for stimulant use disorder
Agranulocytosis Clozapine, neutropenia and lithium Clozapine: uncommon or unusual adverse effects Biochemical and haematological effects of psychotropics Clozapine: serious haematological adverse effects Genetic testing for clozapine treatment
Akathisia Akathisia Relative adverse effects - a rough guide Extrapyramidal symptoms
Albumin psychotropic agent effects hepatic impairment
Alcohol dependence
Alcohol use ataxia disulfiram reaction electrolyte disturbances metabolism of pharmacokinetic interactions sedation amnesia bariatric surgery effects driving impairment health guidance pharmacodynamic interactions psychotropic drug combination
Alcohol Use Disorders Identification Test (AUDIT) 480
Alcohol withdrawal benzodiazepines community detoxification mild seizures severity assessment treatment interventions Alcohol dependence common interventions delirium tremens pharmacologically assisted detoxification severe treating somatic symptoms
Aldehyde dehydrogenase
Alkaline phosphatase in blood, psychotropic agent effects
Alpha blockers, older patients with urinary retention, drug safety
Alternative and experimental treatment of OCD in children and young people
Abilify MyCite, adherence monitoring aid
Absolute risk of intracranial haemorrhage with SSRI with or without anticoagulant or NSAIDs